First Header Logo Second Header Logo

Kevin High

Concepts (453)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Aging
25
2019
946
3.480
Why?
Geriatrics
11
2019
85
2.340
Why?
Geriatric Assessment
7
2019
390
1.320
Why?
Communicable Diseases
5
2009
20
1.220
Why?
Aged
41
2019
10314
1.030
Why?
HIV Infections
5
2015
395
0.990
Why?
Humans
70
2020
32114
0.860
Why?
Community-Acquired Infections
5
2005
32
0.820
Why?
Air Ambulances
2
2016
10
0.800
Why?
Biomedical Research
7
2017
156
0.730
Why?
Herpes Zoster
3
2009
10
0.690
Why?
Dendritic Cells
2
2010
59
0.680
Why?
Respiratory Tract Infections
4
2012
40
0.670
Why?
Interleukin-23
4
2014
21
0.670
Why?
Fever of Unknown Origin
2
2009
10
0.660
Why?
Patient Care Planning
1
2019
58
0.630
Why?
Frail Elderly
4
2019
68
0.620
Why?
Kidney Diseases
4
2014
249
0.620
Why?
Disability Evaluation
1
2019
240
0.610
Why?
Vaccination
2
2010
138
0.590
Why?
Apolipoproteins
3
2014
200
0.590
Why?
JC Virus
2
2014
20
0.580
Why?
Tumor Virus Infections
2
2014
21
0.580
Why?
Polyomavirus Infections
2
2014
21
0.580
Why?
Activities of Daily Living
4
2009
257
0.570
Why?
Lipoproteins, HDL
3
2014
251
0.570
Why?
Pneumonia, Bacterial
3
2005
32
0.550
Why?
Thoracostomy
1
2016
5
0.550
Why?
Pneumothorax
1
2016
8
0.550
Why?
Research
4
2010
74
0.530
Why?
Internal Medicine
4
2006
54
0.520
Why?
Transcription Factors
2
2009
181
0.500
Why?
Comorbidity
8
2015
566
0.500
Why?
Pneumonia
2
2005
68
0.480
Why?
Inflammation
2
2012
530
0.480
Why?
Aging, Premature
1
2013
4
0.460
Why?
Cytokines
2
2012
256
0.450
Why?
Anti-Infective Agents
3
2015
44
0.450
Why?
Aged, 80 and over
12
2019
3990
0.450
Why?
Physical Fitness
2
2012
131
0.450
Why?
Female
28
2019
20015
0.450
Why?
Male
26
2019
19217
0.440
Why?
Wounds and Injuries
1
2016
253
0.440
Why?
T-Lymphocytes
3
2013
124
0.440
Why?
Chronic Disease
6
2016
406
0.440
Why?
Diabetes Complications
1
2014
177
0.430
Why?
United States
14
2017
3976
0.430
Why?
Middle Aged
17
2016
11839
0.420
Why?
Bacterial Translocation
1
2012
9
0.420
Why?
Acute-Phase Proteins
1
2012
10
0.420
Why?
Membrane Glycoproteins
2
2012
101
0.420
Why?
Models, Immunological
1
2012
9
0.420
Why?
Panax
1
2012
8
0.400
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2012
18
0.400
Why?
Health Services Research
1
2012
82
0.400
Why?
Virus Diseases
2
2012
22
0.400
Why?
B-Lymphocytes
3
2010
74
0.390
Why?
Carrier Proteins
1
2012
136
0.390
Why?
Medicine
4
2017
38
0.390
Why?
Plant Extracts
1
2012
61
0.390
Why?
Models, Biological
1
2013
392
0.380
Why?
Idiopathic Pulmonary Fibrosis
1
2010
7
0.370
Why?
Health Priorities
1
2010
15
0.370
Why?
Dinoprostone
1
2010
31
0.360
Why?
Clostridium difficile
3
2016
12
0.360
Why?
Evidence-Based Practice
1
2010
28
0.350
Why?
Adult
15
2016
9380
0.350
Why?
African Americans
2
2014
1425
0.340
Why?
Interleukin-12
3
2014
28
0.340
Why?
Acute Disease
2
2012
253
0.340
Why?
Herpes Zoster Vaccine
1
2009
4
0.340
Why?
Interleukin-23 Subunit p19
1
2009
11
0.340
Why?
Transportation of Patients
2
2009
26
0.330
Why?
Histones
1
2009
53
0.330
Why?
Homes for the Aged
1
2009
20
0.330
Why?
Patient Care Management
1
2009
18
0.330
Why?
Nursing Homes
1
2009
42
0.320
Why?
Antibodies, Bacterial
2
2013
32
0.320
Why?
Cross Infection
1
2009
55
0.320
Why?
Risk Factors
10
2016
3880
0.310
Why?
Cytomegalovirus Infections
4
2013
48
0.310
Why?
Herpesvirus Vaccines
1
2007
1
0.300
Why?
Herpesvirus 3, Human
1
2007
4
0.300
Why?
Animals
13
2015
7542
0.300
Why?
Brucella abortus
1
2007
2
0.300
Why?
Brucellosis
1
2007
7
0.300
Why?
Viral Vaccines
1
2007
11
0.300
Why?
Home Infusion Therapy
1
2007
1
0.290
Why?
Home Care Services, Hospital-Based
1
2007
3
0.290
Why?
Immunization
1
2007
33
0.290
Why?
Neuralgia
1
2007
48
0.290
Why?
Patient Acceptance of Health Care
1
2009
172
0.290
Why?
Cardiovascular Diseases
2
2014
1128
0.280
Why?
Health Services Accessibility
1
2009
242
0.280
Why?
Congresses as Topic
4
2019
41
0.280
Why?
Gene Expression Regulation
1
2009
495
0.280
Why?
Specialization
3
2019
31
0.270
Why?
Hematopoietic Stem Cell Transplantation
2
2007
94
0.270
Why?
Apoptosis
4
2006
360
0.270
Why?
Antigens, Surface
1
2005
24
0.270
Why?
Individuality
1
2005
9
0.260
Why?
Mice
7
2015
2484
0.260
Why?
Spleen
1
2005
87
0.250
Why?
Hospitals, University
1
2005
31
0.250
Why?
Prognosis
6
2013
1497
0.250
Why?
Immunologic Factors
1
2005
49
0.250
Why?
Skin Ulcer
2
2015
11
0.250
Why?
Clostridium Infections
2
2016
9
0.250
Why?
Malnutrition
1
2005
17
0.250
Why?
Trauma Centers
1
2005
82
0.250
Why?
Influenza Vaccines
3
2014
78
0.240
Why?
Long-Term Care
4
2014
25
0.240
Why?
Health Status Indicators
1
2004
73
0.240
Why?
Hepatitis C, Chronic
2
2015
77
0.230
Why?
Prostaglandin D2
2
2005
5
0.230
Why?
Postural Balance
1
2016
182
0.230
Why?
Cognition
2
2005
556
0.230
Why?
Anti-Bacterial Agents
3
2013
324
0.220
Why?
Pesticides
1
2016
199
0.220
Why?
alpha-Tocopherol
1
2002
1
0.220
Why?
Occupational Exposure
1
2016
232
0.220
Why?
Receptors, Cytoplasmic and Nuclear
1
2002
12
0.210
Why?
Mucous Membrane
1
2002
20
0.210
Why?
Vitamin A
1
2002
21
0.210
Why?
Awards and Prizes
1
2002
11
0.210
Why?
Emigrants and Immigrants
1
2016
244
0.210
Why?
Transients and Migrants
1
2016
297
0.210
Why?
Incidence
4
2012
1199
0.210
Why?
Hematologic Neoplasms
1
2002
35
0.200
Why?
Academic Medical Centers
1
2002
158
0.190
Why?
Stem Cell Transplantation
1
2002
209
0.190
Why?
Intubation, Intratracheal
2
2019
71
0.180
Why?
Age Factors
6
2015
1189
0.180
Why?
Young Adult
4
2016
2665
0.180
Why?
Health Services Needs and Demand
2
2012
81
0.180
Why?
Education, Medical
2
2019
69
0.180
Why?
Attitude of Health Personnel
1
2002
184
0.180
Why?
Evidence-Based Medicine
2
2014
218
0.180
Why?
Treatment Outcome
6
2016
3306
0.170
Why?
Linear Models
4
2015
449
0.170
Why?
Staff Development
1
2019
16
0.170
Why?
Forecasting
4
2020
143
0.170
Why?
Continuous Positive Airway Pressure
1
2019
5
0.170
Why?
Hispanic Americans
1
2016
940
0.170
Why?
Mice, Inbred C57BL
3
2013
767
0.170
Why?
Up-Regulation
2
2010
189
0.170
Why?
Teaching
1
2019
63
0.170
Why?
Breast Neoplasms
2
2002
765
0.170
Why?
Mentors
1
2019
31
0.160
Why?
Faculty, Medical
1
2019
78
0.160
Why?
Age Distribution
3
2013
206
0.160
Why?
Leadership
1
2019
37
0.160
Why?
Physical Therapy Modalities
1
2019
64
0.160
Why?
Immunity, Innate
2
2016
75
0.150
Why?
PPAR gamma
2
2015
46
0.150
Why?
Safety
2
2009
77
0.150
Why?
Adolescent
4
2016
3568
0.140
Why?
Mobility Limitation
1
2019
219
0.140
Why?
Career Mobility
1
2017
16
0.140
Why?
Severity of Illness Index
4
2015
881
0.140
Why?
Wound Healing
2
2015
185
0.140
Why?
Mice, Inbred DBA
2
2007
40
0.140
Why?
Acquired Immunodeficiency Syndrome
1
2016
16
0.140
Why?
Kidney Failure, Chronic
2
2012
543
0.140
Why?
Empyema
1
2016
1
0.140
Why?
Chest Tubes
1
2016
5
0.140
Why?
Cardiopulmonary Resuscitation
1
2016
24
0.130
Why?
Arachidonic Acid
2
2006
35
0.130
Why?
Lymphocyte Count
2
2005
24
0.130
Why?
Cell Survival
4
2010
285
0.130
Why?
PPAR alpha
1
2015
29
0.130
Why?
Morbidity
2
2007
98
0.130
Why?
Mice, Inbred BALB C
3
2014
167
0.130
Why?
Surgical Wound Infection
1
2016
84
0.130
Why?
Aviation
1
2015
2
0.130
Why?
Electric Stimulation Therapy
1
2015
14
0.120
Why?
CD8-Positive T-Lymphocytes
2
2005
91
0.120
Why?
Negative-Pressure Wound Therapy
1
2015
35
0.120
Why?
Retrospective Studies
4
2016
3510
0.120
Why?
Adaptive Immunity
2
2013
16
0.120
Why?
Hyperglycemia
1
2014
84
0.120
Why?
RNA, Messenger
1
2015
508
0.120
Why?
Digestive System
1
2013
3
0.120
Why?
Double-Blind Method
2
2013
525
0.110
Why?
Influenzavirus A
1
2013
1
0.110
Why?
Virion
1
2013
7
0.110
Why?
Population Groups
1
2013
7
0.110
Why?
Central Nervous System Neoplasms
1
2014
29
0.110
Why?
Adjuvants, Immunologic
1
2014
55
0.110
Why?
Patient Care
1
2014
30
0.110
Why?
Multivariate Analysis
2
2012
684
0.110
Why?
Mass Vaccination
1
2013
9
0.110
Why?
Eye
1
2013
15
0.110
Why?
Pneumonia, Pneumococcal
1
2013
12
0.110
Why?
Societies, Medical
3
2017
164
0.110
Why?
B-Lymphocyte Subsets
1
2013
18
0.110
Why?
Pneumococcal Vaccines
1
2013
26
0.110
Why?
Hepatitis B Vaccines
1
2013
10
0.110
Why?
Hepatitis B
1
2013
17
0.110
Why?
Enterocolitis, Pseudomembranous
1
2013
9
0.110
Why?
Gene Expression Regulation, Neoplastic
2
2006
261
0.110
Why?
Diabetes Mellitus
1
2016
412
0.110
Why?
Bile Duct Diseases
1
2013
10
0.110
Why?
Glioma
1
2014
136
0.110
Why?
Polypharmacy
1
2012
17
0.100
Why?
Program Development
2
2019
97
0.100
Why?
Hand Strength
1
2012
101
0.100
Why?
Osteoarthritis
1
2013
79
0.100
Why?
Influenza, Human
1
2013
122
0.100
Why?
Inflammation Mediators
1
2012
104
0.100
Why?
Disease Models, Animal
2
2014
1022
0.100
Why?
Bone Marrow Cells
2
2010
123
0.100
Why?
Needs Assessment
1
2012
76
0.100
Why?
Anti-HIV Agents
1
2012
55
0.100
Why?
Cross-Sectional Studies
2
2015
1542
0.100
Why?
Blood Glucose
1
2014
494
0.100
Why?
Muscle Fibers, Skeletal
1
2012
109
0.100
Why?
Gait
1
2012
142
0.100
Why?
Membrane Proteins
1
2013
256
0.100
Why?
Survival Rate
2
2005
877
0.100
Why?
Exercise Test
1
2012
227
0.100
Why?
Genetic Variation
1
2012
244
0.090
Why?
Sensitivity and Specificity
1
2012
582
0.090
Why?
Postoperative Complications
1
2016
780
0.090
Why?
African Continental Ancestry Group
1
2012
363
0.090
Why?
Promoter Regions, Genetic
2
2009
208
0.090
Why?
Practice Guidelines as Topic
1
2014
408
0.090
Why?
Shoulder Joint
1
2013
126
0.090
Why?
Toll-Like Receptor 8
1
2010
5
0.090
Why?
Receptors, Prostaglandin E
1
2010
4
0.090
Why?
Toll-Like Receptor 7
1
2010
9
0.090
Why?
Flow Cytometry
3
2005
185
0.090
Why?
CD4-Positive T-Lymphocytes
2
2013
55
0.090
Why?
Health Planning Guidelines
1
2010
5
0.090
Why?
Creatinine
1
2011
195
0.090
Why?
Antigen-Presenting Cells
1
2010
6
0.090
Why?
Motor Activity
1
2013
325
0.090
Why?
Telomere
1
2010
10
0.090
Why?
Signal Transduction
2
2013
682
0.090
Why?
Toll-Like Receptor 4
1
2010
40
0.090
Why?
Immunization Schedule
1
2010
26
0.090
Why?
Transforming Growth Factor beta
1
2010
64
0.090
Why?
Syndrome
2
2013
72
0.090
Why?
Proto-Oncogene Proteins c-rel
1
2009
1
0.090
Why?
Nurses
1
2009
15
0.090
Why?
Chromatin
1
2009
25
0.080
Why?
Neoplasms
1
2016
728
0.080
Why?
Nursing Diagnosis
1
2009
2
0.080
Why?
Body Temperature
1
2009
20
0.080
Why?
Triazenes
2
2006
4
0.080
Why?
Interleukin-6
1
2010
247
0.080
Why?
Diagnostic Tests, Routine
1
2009
24
0.080
Why?
Tissue Engineering
1
2015
656
0.080
Why?
Time Factors
3
2004
2151
0.080
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
153
0.080
Why?
Interdisciplinary Communication
1
2009
58
0.080
Why?
Disease Outbreaks
1
2009
43
0.080
Why?
Metabolic Diseases
1
2008
18
0.080
Why?
Analysis of Variance
2
2015
464
0.080
Why?
Immunity
1
2008
22
0.080
Why?
Physical Examination
1
2009
92
0.080
Why?
Antiretroviral Therapy, Highly Active
1
2008
29
0.080
Why?
HIV-1
1
2008
45
0.080
Why?
Physician Assistants
1
2009
41
0.080
Why?
Liver Diseases
1
2008
70
0.080
Why?
Lymphocyte Depletion
1
2007
17
0.080
Why?
Aspergillosis
1
2007
8
0.080
Why?
Muscle, Skeletal
1
2012
519
0.080
Why?
Opportunistic Infections
1
2007
17
0.080
Why?
Health Services for the Aged
1
2007
25
0.080
Why?
Bone Marrow Transplantation
1
2007
63
0.070
Why?
Superoxide Dismutase
1
2007
45
0.070
Why?
Th1 Cells
1
2007
25
0.070
Why?
Infusions, Intravenous
1
2007
100
0.070
Why?
Immunoglobulin G
1
2007
122
0.070
Why?
Liver
3
2015
484
0.070
Why?
Antigens, CD
2
2004
103
0.070
Why?
Education, Medical, Continuing
2
2006
55
0.070
Why?
North Carolina
2
2016
1538
0.070
Why?
Risk Assessment
3
2012
1429
0.070
Why?
Transcription, Genetic
2
2006
137
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2005
22
0.070
Why?
Program Evaluation
1
2006
186
0.070
Why?
Receptors, IgG
1
2005
7
0.070
Why?
Nitrobenzenes
1
2005
10
0.070
Why?
Drug Resistance, Microbial
1
2005
14
0.070
Why?
Receptors, Eicosanoid
1
2005
3
0.070
Why?
Immunologic Memory
1
2005
32
0.070
Why?
Colonic Neoplasms
1
2006
71
0.070
Why?
Renal Insufficiency, Chronic
1
2009
291
0.060
Why?
Arachidonic Acids
1
2005
23
0.060
Why?
Chronology as Topic
1
2005
1
0.060
Why?
Emergency Medical Service Communication Systems
1
2005
3
0.060
Why?
Organophosphorus Compounds
1
2005
33
0.060
Why?
Emergency Medical Technicians
1
2005
11
0.060
Why?
Statistics as Topic
1
2005
108
0.060
Why?
Tennessee
1
2005
102
0.060
Why?
Clinical Competence
2
2005
333
0.060
Why?
Imidazoles
1
2005
91
0.060
Why?
Sulfonamides
1
2005
67
0.060
Why?
Neutrophils
1
2005
106
0.060
Why?
Nutrition Assessment
1
2005
55
0.060
Why?
Disease Susceptibility
2
2016
57
0.060
Why?
Research Design
2
2006
315
0.060
Why?
Sex Distribution
1
2005
191
0.060
Why?
Cytomegalovirus
1
2004
31
0.060
Why?
Drug Therapy, Combination
1
2005
288
0.060
Why?
Phenotype
3
2013
632
0.060
Why?
Hematopoiesis
1
2004
33
0.060
Why?
Models, Theoretical
1
2005
137
0.060
Why?
Familial Mediterranean Fever
1
2003
2
0.060
Why?
Genetic Heterogeneity
1
2003
14
0.060
Why?
Periodicity
1
2003
11
0.060
Why?
Population Dynamics
1
2003
6
0.060
Why?
Receptors, Tumor Necrosis Factor
1
2003
46
0.060
Why?
Hematopoietic Stem Cells
1
2004
100
0.060
Why?
Case-Control Studies
1
2016
898
0.060
Why?
Retirement
1
2003
13
0.060
Why?
Biopsy
2
2015
259
0.050
Why?
Reproducibility of Results
1
2005
765
0.050
Why?
Tocopherols
1
2002
3
0.050
Why?
Training Support
1
2002
5
0.050
Why?
Response Elements
1
2002
16
0.050
Why?
Cell Proliferation
1
2005
604
0.050
Why?
Mortality
1
2004
125
0.050
Why?
Research Support as Topic
1
2002
26
0.050
Why?
Protein Transport
1
2002
74
0.050
Why?
Fluoroquinolones
1
2002
11
0.050
Why?
Fluorescent Antibody Technique
1
2002
91
0.050
Why?
Leukemia
1
2002
40
0.050
Why?
Lymphoma
1
2002
35
0.050
Why?
Demography
1
2002
110
0.050
Why?
Tumor Cells, Cultured
1
2002
171
0.050
Why?
Developing Countries
1
2002
48
0.050
Why?
Transplantation Conditioning
1
2002
13
0.050
Why?
Health Status
1
2004
400
0.050
Why?
Chi-Square Distribution
2
2013
297
0.050
Why?
Cell Nucleus
1
2002
108
0.050
Why?
Albuminuria
2
2013
181
0.050
Why?
Child
1
2008
2442
0.050
Why?
Glomerular Filtration Rate
2
2013
308
0.050
Why?
Residence Characteristics
1
2003
202
0.050
Why?
Data Collection
1
2002
182
0.050
Why?
Educational Status
1
2002
181
0.050
Why?
Depression
1
2004
445
0.050
Why?
Physicians
1
2003
159
0.050
Why?
Diagnosis, Differential
1
2002
517
0.040
Why?
Disease Progression
2
2015
594
0.040
Why?
Insurance, Health
1
2020
95
0.040
Why?
Video Recording
1
2019
59
0.040
Why?
Genetic Predisposition to Disease
2
2013
835
0.040
Why?
Respiration, Artificial
1
2019
99
0.040
Why?
Pedigree
2
2012
140
0.040
Why?
Curriculum
1
2019
214
0.040
Why?
Host-Pathogen Interactions
1
2016
24
0.030
Why?
Caspase 3
2
2005
33
0.030
Why?
Caspases
2
2005
39
0.030
Why?
Reference Values
1
2015
246
0.030
Why?
Liver Cirrhosis
1
2015
81
0.030
Why?
Canada
1
2015
56
0.030
Why?
Tracheostomy
1
2015
29
0.030
Why?
Immunity, Mucosal
1
2014
5
0.030
Why?
Administration, Topical
1
2015
140
0.030
Why?
Immunoglobulin A
1
2014
12
0.030
Why?
Influenza A Virus, H3N2 Subtype
1
2014
23
0.030
Why?
Influenza B virus
1
2014
20
0.030
Why?
Orthomyxoviridae Infections
1
2014
20
0.030
Why?
Vaccines, Inactivated
1
2014
38
0.030
Why?
Viral Load
1
2014
70
0.030
Why?
Antibodies, Viral
1
2014
58
0.030
Why?
Immunity, Active
1
2013
1
0.030
Why?
Polysaccharides, Bacterial
1
2013
10
0.030
Why?
Transgenes
1
2013
48
0.030
Why?
Immunity, Humoral
1
2013
13
0.030
Why?
Immunomodulation
1
2013
32
0.030
Why?
Regression Analysis
1
2014
293
0.030
Why?
Hepatitis B Antibodies
1
2013
1
0.030
Why?
Cystatin C
1
2013
31
0.030
Why?
Nonlinear Dynamics
1
2013
51
0.030
Why?
DNA, Viral
1
2013
54
0.030
Why?
Cell Line, Tumor
2
2005
726
0.030
Why?
Liver Cirrhosis, Biliary
1
2013
7
0.030
Why?
Jaundice
1
2013
5
0.030
Why?
Gene Expression
2
2005
338
0.030
Why?
Cholestasis
1
2013
18
0.030
Why?
Interleukin-17
1
2013
26
0.030
Why?
Disease Management
1
2014
126
0.030
Why?
Anti-Retroviral Agents
1
2013
21
0.030
Why?
Isotonic Contraction
1
2012
8
0.030
Why?
Myofibrils
1
2012
8
0.030
Why?
Secondary Prevention
1
2013
63
0.030
Why?
Length of Stay
1
2014
314
0.030
Why?
Heredity
1
2012
13
0.030
Why?
Physical Conditioning, Animal
1
2012
32
0.030
Why?
Models, Animal
1
2013
169
0.030
Why?
Lung
1
2014
249
0.030
Why?
Pilot Projects
1
2014
548
0.030
Why?
Muscular Atrophy
1
2012
71
0.030
Why?
Gene Frequency
1
2012
220
0.030
Why?
Range of Motion, Articular
1
2013
187
0.030
Why?
Myosin Heavy Chains
1
2012
89
0.030
Why?
Monocytes
1
2013
127
0.020
Why?
Hospitalization
1
2014
470
0.020
Why?
Prevalence
1
2013
989
0.020
Why?
Quality of Life
1
2015
946
0.020
Why?
Prospective Studies
1
2014
2283
0.020
Why?
Kidney
1
2012
518
0.020
Why?
Cyclosporine
1
2007
49
0.020
Why?
Tomography, X-Ray Computed
1
2013
919
0.020
Why?
Graft vs Host Disease
1
2007
21
0.020
Why?
Transplantation, Homologous
1
2007
151
0.020
Why?
Methotrexate
1
2007
64
0.020
Why?
Immunosuppression
1
2007
121
0.020
Why?
Certification
1
2006
27
0.020
Why?
HCT116 Cells
1
2006
11
0.020
Why?
Survival Analysis
1
2007
483
0.020
Why?
Proto-Oncogene Proteins c-jun
1
2006
7
0.020
Why?
Transcription Factor AP-1
1
2006
19
0.020
Why?
Immunosuppressive Agents
1
2007
240
0.020
Why?
Coenzyme A Ligases
1
2005
2
0.020
Why?
Acyltransferases
1
2005
16
0.020
Why?
Peroxisome Proliferator-Activated Receptors
1
2005
3
0.020
Why?
Hydroxyeicosatetraenoic Acids
1
2005
2
0.020
Why?
Anilides
1
2005
10
0.020
Why?
Pertussis Toxin
1
2005
17
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2005
10
0.020
Why?
Interviews as Topic
1
2006
266
0.020
Why?
Mitosis
1
2005
25
0.020
Why?
Drug Synergism
1
2005
66
0.020
Why?
Hela Cells
1
2005
79
0.020
Why?
Binding Sites
1
2005
130
0.020
Why?
Protein Binding
1
2005
201
0.020
Why?
Transfection
1
2005
191
0.020
Why?
Organizational Objectives
1
2004
23
0.020
Why?
Cell Line
1
2005
435
0.010
Why?
ADP-ribosyl Cyclase
1
2004
4
0.010
Why?
Antigens, CD34
1
2004
57
0.010
Why?
Virus Replication
1
2004
42
0.010
Why?
Founder Effect
1
2003
5
0.010
Why?
Kinetics
1
2004
209
0.010
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2003
13
0.010
Why?
Polymerase Chain Reaction
1
2004
198
0.010
Why?
Microsatellite Repeats
1
2003
21
0.010
Why?
Family Health
1
2003
78
0.010
Why?
Cohort Studies
1
2007
1817
0.010
Why?
Haplotypes
1
2003
220
0.010
Why?
Cell Culture Techniques
1
2004
173
0.010
Why?
Tissue Donors
1
2004
198
0.010
Why?
Probability
1
2002
159
0.010
Why?
Administration, Oral
1
2002
187
0.010
Why?
Drug Administration Schedule
1
2002
276
0.010
Why?
Dose-Response Relationship, Drug
1
2002
633
0.010
Why?
Follow-Up Studies
1
2002
2265
0.010
Why?
High's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (453)
Explore
_
Co-Authors (45)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_